We are proud to announce that PhenoPath is now a Quest Diagnostics Company.

INI-1 (SMARCB1) pin

IHC

INI-1 (SMARCB1)

Methodology: IHC

Clinical Significance:
Identifies: The gene product of the INI-1 gene, also referred to as BAF47. This is a tumor suppressor gene, inactivation through mutation or other mechanism characterizes a unique subset of tumors that includes renal and extrarenal rhabdoid tumors, atypical teratoid/rhabdoid tumors of the central nervous system, distal and proximal variants of epithelioid sarcoma, as well as a subset of mesenchymal chondrosarcomas, epithelioid malignant peripheral nerve sheath tumors, and soft tissue myoepitheliomas. Loss of immunostaining is the characteristic feature of these tumors. Subcellular Localization: Nuclear

Organ: Brain/CNS

Disease State: Small, Blue, Round Cell Tumors

CPT Code(s): 88342 or 88341. The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Turnaround Time: Within 1-2 business days of receipt

Schedule: Monday - Friday

Specimen Requirements:
• Formalin-fixed, paraffin-embedded (FFPE) tissue block or cell block - OR - • 1 unstained slide for each test requested plus 3-4 additional unstained slides cut at 4µm